Advances in Clinical Biochemistry Laboratory Quality Assurance: Analytical Accuracy, Error Prevention, and Diagnostic Reliability

Authors

  • Nnamdi Eneh Independent National Electoral Commission (INEC) Staff Clinics, Abuja, Nigeria
  • Kazeem Abdulrazaq General Hospital Doma, Nasarawa, Nigeria
  • Habeeb Damilola Yusuf Healthwise Social Enterprise, Nigeria
  • Olatunde Adesoji Aladegba Department of Chemistry, University of Lagos, Lagos, Nigeria

DOI:

https://doi.org/10.30750/ijpbr.6.4.11

Keywords:

Quality assurance, internal quality control, external quality assessment, total testing process, laboratory error, Six Sigma, metrological traceability, analytical performance specifications, ISO 15189, patient safety

Abstract

Clinical biochemistry results inform a large share of medical decisions, from screening and diagnosis to therapeutic monitoring and prognosis. The reliability of these results depends on a quality assurance system that spans the entire testing process, not only the analytical phase. Over the past two decades, laboratory medicine has moved from a narrow focus on internal quality control of instruments toward a patient-centred view of quality that includes test selection, specimen collection, analysis, reporting, and interpretation. This review summarises the advances in clinical biochemistry quality assurance up to 2018 and situates them within related work on laboratory infrastructure, disease surveillance, safety and risk management, maintenance engineering, and data governance. It examines the epidemiology of laboratory errors across the total testing process, the evolution of internal quality control from Levey- Jennings charts and Westgard multirules to risk-based and Six Sigma designs, the role of external quality assessment and metrological traceability in achieving harmonised and accurate results, and the 2015 Milan consensus on analytical performance specifications. It also considers pre-analytical and post-analytical error prevention, quality indicators, accreditation to ISO 15189:2012, the impact of total laboratory automation and middleware, and quality management of point-of-care testing. The evidence shows that while analytical error rates have fallen dramatically, extra-analytical phases now account for most errors, and that genuine diagnostic reliability requires integrating analytical excellence with process control, standardisation, and clinical communication.

Downloads

Published

2018-12-17

How to Cite

1.
Eneh N, Abdulrazaq K, Yusuf HD, Aladegba OA. Advances in Clinical Biochemistry Laboratory Quality Assurance: Analytical Accuracy, Error Prevention, and Diagnostic Reliability. IJPBR [Internet]. 2018Dec.17 [cited 2026Nov.16];6(04):55-67. Available from: https://ijpbr.in/index.php/IJPBR/article/view/1436